To examine depression and anxiety screens and their individual items as simultaneous predictors of incident diabetes mellitus. DESIGN: Ten-year follow-up study of individuals screened for the Improving Mood-Promoting Access to Collaborative Treatment (IMPACT) trial. SETTING: Two large urban primary care clinics in Indianapolis, Indiana. PARTICIPANTS: Diverse sample (53% African American, 80% of lower socioeconomic status) of 2,156 older adults initially free of diabetes mellitus. MEASUREMENTS: Depression and anxiety screens were completed during routine primary care visits between 1999 and 2001. Incident diabetes mellitus data were obtained from an electronic medical record system and the Centers for Medicare and Medicaid Services analytical files though 2009. RESULTS: Over the 10-year period, 558 (25.9%) participants had diabetes mellitus onset. Cox proportional hazards models adjusted for demographic and diabetes mellitus risk factors revealed that a positive screen for anxiety, but not for depression, predicted incident diabetes mellitus when entered into separate models (anxiety: hazard ratio (HR) = 1.36, 95% confidence interval (CI) = 1.15-1.61, P < .001; depression: HR = 1.18, 95% CI = 0.95-1.46, P = .13) and when entered simultaneously into one model (anxiety: HR = 1.35, 95% CI = 1.12-1.61, P < .001; depression: HR = 1.04, 95% CI = 0.83-1.31, P = .73). The feeling anxious (P = .03) and the worry (P = .02) items predicted incident diabetes mellitus independent of the depression screen.
motional factors, namely depression and anxiety, have been increasingly linked to the incidence of diabetes mellitus. Depression has received the most attention, with meta-analyses indicating that adults with depression have a 37-60% greater risk of developing diabetes mellitus than those without depression. 1, 2 Anxiety has received much less attention, and most studies assessing anxiety are crosssectional. 3 As a consequence, the directionality of the association between anxiety and diabetes mellitus is undetermined.
Another critical limitation of these literatures is that nearly all existing studies have examined these emotional factors in isolation, which is problematic given their considerable overlap. To illustrate, depressive and anxiety disorders are highly comorbid (55-60%), 4 and self-report measures of depressive and anxiety symptoms are strongly correlated (correlation coefficient = 0.45-0.75). 5 When only one emotional factor is examined at a time, it remains unclear whether an observed association reflects the measured factor, a closely related but unmeasured factor, or a broader construct encompassing both factors. 6 Unfortunately, the few prospective studies that have examined more than one emotional factor predicting diabetes mellitus outcomes cannot distinguish between depression and anxiety because of their heterogeneous methodology and operationalization of variables. [7] [8] [9] [10] Specifically, two recent Swedish studies used a composite index of psychological distress. 8, 9 A third study combined participants with depression, anxiety disorders, or both, 7 and a fourth examined depression and anxiety separately. 10 The lack of diversity of the study samples is also noteworthy, given that all but one of these studies were conducted with European samples. Depression and anxiety have not been simultaneously examined as predictors of incident diabetes mellitus in samples with greater racial, ethnic, and socioeconomic diversity.
Determining whether depression, anxiety, or both are independent predictors of future diabetes mellitus could have important implications for the design of diabetes mellitus prevention programs, yet the relative contribution of these emotional factors to the risk of developing diabetes mellitus is unknown. Therefore, the primary objective of this study was to examine depression and anxiety screens simultaneously as predictors of 10-year incidence of diabetes mellitus. A secondary objective was to examine individual depression and anxiety screen items to explore whether specific symptoms are stronger predictors of incident diabetes mellitus than others. Characteristics of the study that increase the clinical relevance and ecological validity of the findings include sample diversity (high percentage of African Americans and medically uninsured or underinsured individuals), individual risk factor profile (older adults with higher diabetes mellitus risk factor burden), and clinical setting (primary care).
METHODS

Participants
The Improving Mood-Promoting Access to Collaborative Treatment (IMPACT) trial was a multisite randomized controlled trial examining the effectiveness of collaborative care for late-life depression (see 11 for detailed methods; ClinicalTrials.gov Identifier: NCT01561105). From July 1999 to August 2001, all 3,675 individuals aged 60 and older attending two large urban primary care clinics in a safety net healthcare system in Indianapolis, Indiana, were approached for screening for the IMPACT trial during routine visits. Roughly 80% were economically disadvantaged as indicated by receiving federal or county health insurance assistance. 12 Of these 3,675 individuals, 172 refused screening, and five had incomplete screens. The IMPACT trial data of an additional 25 could not be matched with data from other sources. Of the remaining 3,473 individuals, 1,317 (37.9%) who had diabetes mellitus (type 1 or type 2) at baseline were excluded, given that the study focus was on predicting new-onset diabetes mellitus. To determine baseline diabetes mellitus status, data from the Regenstrief Medical Record System (RMRS), 13 15 recommend the use of a higher cut point (8.0-9.0%) for diabetes mellitus diagnosis in older adults with comorbid conditions, such as those who underwent screening for the IMPACT trial. The more-conservative cut point in this range was chosen. One hundred-twenty-three individuals enrolled in the IMPACT trial were included in the current analyses because a separate analysis of these individuals revealed that the depression intervention had no effect on incident diabetes mellitus, and sensitivity analyses excluding these 123 individuals revealed that the pattern of results and magnitude of effects did not change (data not shown). Table 1 presents the baseline characteristics of the 2,156 participants in the final sample.
The Indiana University-Purdue University Indianapolis institutional review board and the CMS privacy board approved the use of RMRS and CMS follow-up data for Indiana participants of the IMPACT trial. The depression and anxiety screens were administered as part of routine care. A waiver of consent was obtained to link RMRS and CMS data.
Measures and Procedures
Baseline Depression and Anxiety Screens
During routine primary care visits between July 1999 and August 2001, participants underwent screening for the IMPACT trial by completing a modified version of the Primary Care Evaluation of Mental Disorders (PRIME-MD) Patient Health Questionnaire (PHQ). 16 In the modified version, some items were omitted because of screening time constraints. The PHQ is a self-report symptom measure used to screen medical patients for common psychiatric disorders. Participants responded yes or no to the question: "During the past month, have you been bothered participants who endorsed either of the two depression or anxiety items were coded as screening positive for depression or anxiety, respectively. The complete PRIME-MD procedure includes a follow-up interview to confirm diagnoses of individuals who screen positive for a disorder. This structured interview was not completed in the current study. Nonetheless, the PHQ depression screen has moderate sensitivity (69%) and high specificity (82%) for depressive disorder diagnoses made by mental health professionals, and the anxiety screen has higher sensitivity (94%) and lower specificity (53%) for anxiety disorder diagnoses. 16 
Incident Diabetes Mellitus
Cases of incident diabetes mellitus were identified using RMRS data merged with CMS data (Medicare and Medicaid claims). Incident diabetes mellitus was defined as the first occurrence of any of the following between the participant's IMPACT screening date (1999-2001) and December 31, 2009: diabetes mellitus diagnosis (ICD-9 code 250), fasting glucose of 126 mg/dL or greater, HbA 1c of 8.0% or greater, prescription for insulin or oral hypoglycemic medication, or death due to diabetes mellitus (ICD-10 codes E10-E14 as first-listed cause of death). Death dates were extracted from the Medicare data, and causes of death were obtained from death certificates provided by the Indiana State Department of Health and included in the RMRS. Participants were followed for a maximum of 10.5 years (median 8.5 years).
Other Baseline Factors
Baseline factors, assessed at or before each participant's IMPACT screening date, included demographic factors (age, sex, race) and diabetes mellitus risk factors (hypertension, hypercholesterolemia, smoking, body mass index (BMI)). Information on demographic characteristics and physician-diagnosed hypertension was extracted from the RMRS, as described previously. 12 For each participant, the most-recent total cholesterol level during the 5-year window preceding each participant's IMPACT screening date was extracted from the RMRS, and participants with a value of 240 mg/dL or greater were coded as having hypercholesterolemia. Data on lipid lowering medication use were not extracted, so this information was not available to determine baseline hypercholesterolemia status. Smoking data were extracted from the RMRS during the same 5-year period preceding each participant's IMPACT screening date, and participants with a positive marker were coded as smokers. Height and weight data recorded in the RMRS before each participant's IMPACT screening date were used to compute BMI (kg/m 2 ). For six (0.3%) participants, missing values for height and weight were imputed with sex-specific median values. In addition to these factors, supplemental analyses used items from the PRIME-MD PHQ administered as part of the screening for the IMPACT trial assessing general perceived health ("Overall, would you say your health is excellent, very good, good, fair, or poor?") and sleep disturbance (feeling tired or having low energy, trouble sleeping).
Data Analysis
To examine the relative contribution of a positive screen for depression and anxiety to the risk of developing diabetes mellitus, a series of Cox proportional hazards models were performed that included demographic factors and diabetes mellitus risk factors as covariates. Participants were censored at their date of death or December 31, 2009. In the individual models, the depression and anxiety screens were entered into separate models as predictor variables. In the simultaneous-entry model, both screens were entered into the same model. For screens that predicted incident diabetes mellitus, Kaplan-Meier survival curves were constructed to illustrate time to diabetes mellitus onset for participants with positive and negative screens. The individual items in the screens that predicted incident diabetes mellitus were also examined. Specifically, the two items were entered as predictor variables in separate models, with and without inclusion of the other screen as a covariate. The proportional hazards assumption was not rejected for models examining depression or anxiety screens or the individual screen items (all P > .096).
Supplemental analyses were conducted to reduce the possibility that impending diabetes mellitus onset results in an individual screening positive for depression or anxiety (reverse causality). To do so, Cox models were rerun after participants who had diabetes mellitus onset in the first year of follow-up were excluded. Second, separate analyses were performed to explore the effect of excluding all participants who died during follow-up and excluding only participants who died without incident diabetes mellitus. Third, analyses adjusting for the PHQ general perceived health item were conducted to decrease the possibility that any observed relationships were due to confounding by poor overall health. Finally, the influence of sleep disturbance on any observed associations was examined by further adjusting for the PHQ items "feeling tired" and "trouble sleeping." Analyses were conducted using SAS version 9.3 (SAS Institute, Inc., Cary, NC).
RESULTS
Depression and Anxiety Screens
Three hundred sixty-five (16.9%) participants screened positive for depression (2.8% little interest item only, 6.3% feeling depressed item only, 7.8% both items), and 958 (44.4%) screened positive for anxiety (10.3% feeling anxious item only, 14.1% worry item only, 20.0% both items). The positive anxiety screen rate was similar to the rates reported for the PHQ in the PRIME-MD validation study (anxiety, 48.6%; depression, 32.5%), but the depression screen rate was lower. 16 A lower rate of positive depression screens may have been observed because the current study sample was older 17 and because individuals with baseline diabetes mellitus were excluded. 18 In the current study sample, 302 (14.0%) participants screened positive for both depression and anxiety, a comorbidity rate similar to that reported in prior studies of individuals in primary care using brief screeners. 19 Correlations between the depression and anxiety screen variables were in the moderate range (phi coefficients = 0.35-0.44).
Incident Diabetes Mellitus
Over the 10 years of follow-up, 558 (25.
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Depression and Anxiety Screens as Predictors of Incident Diabetes Mellitus
Individual Cox proportional hazards models adjusted for demographic and diabetes mellitus risk factors revealed that a positive anxiety screen (P < .001), but not a positive depression screen (P = .13), predicted incident diabetes mellitus (Table 2) . A positive anxiety screen was associated with a 36% greater risk of incident diabetes mellitus over the 10-year follow-up period. The simultaneous-entry Cox model similarly revealed that a positive anxiety screen (P < .001), but not a positive depression screen (P = .73), predicted incident diabetes mellitus. In this model, a positive anxiety screen was associated with a 35% greater diabetes mellitus risk. In addition to the anxiety screen, BMI (HR = 1.04, 95% CI = 1.03-1.05, P < .001), male sex (HR = 1.24, 95% CI = 1.03-1.50, P = .02), and smoking (HR = 1.21, 95% CI = 1.01-1.45, P = .03) predicted incident diabetes mellitus. The interaction between the depression screen and the anxiety screen was not significant (P = .63). Figure 1 displays the Kaplan-Meier survival curves illustrating time to diabetes mellitus onset for participants with positive and negative anxiety screens.
Given that the anxiety screen independently predicted incident diabetes mellitus, the two items that make up this measure were examined (Table 2 ). In individual Cox models, the feeling anxious item (P = .01, 26% greater risk) and the worry item (P = .006, 28% greater risk) predicted incident diabetes mellitus. In models additionally adjusted for depression screen, a similar pattern of results was observed, with the feeling anxious item (P = .03, 23% greater risk) and the worry item (P = .02, 25% greater risk) remaining predictive of incident diabetes mellitus.
Supplemental Analyses
Examining the association between positive anxiety screen and incident diabetes mellitus only, Cox models were repeated after excluding the 91 participants who had diabetes mellitus onset in the first year of follow-up. A positive anxiety screen remained predictive of incident diabetes mellitus (HR = 1.36, 95% CI = 1.13-1.64, P = .001), as did the feeling anxious item (HR = 1.28, 95% CI = 1.06-1.56, P = .01) and the worry item (HR = 1.24, 95% CI = 1.02-1.50, P = .03) in their individual models. A positive anxiety screen also predicted incident diabetes mellitus when Cox models were rerun after excluding all 809 participants who died during follow-up (HR = 1.33, 95% CI = 1.08-1.64, P = .007) and excluding 622 participants who died without incident diabetes mellitus (HR = 1.38, 95% CI = 1.17-1.64, P = .001). Moreover, when further adjusted for general perceived health (PRIME-MD perceived health item) or sleep disturbance (PRIME-MD feeling tired and trouble sleeping items), a positive anxiety screen continued to predict incident diabetes mellitus in its individual model (perceived health-adjusted model: HR = 1.30, 95% CI = 1.08-1.55, P = .005; sleep disturbance-adjusted model: HR = 1.26, 95% CI = 1.05-1.52, P = .01). Item-level analyses revealed that the feeling anxious item and the worry item continued to predict incident diabetes mellitus when adjusted for perceived health (feeling anxious item: HR = 1.21, 95% CI = 1.01-1.47, P = .04; worry item: HR = 1.21, 95% CI = 1.01-1.46, P = .04) but fell short of significance when adjusted for sleep disturbance (feeling anxious item: HR = 1.15, 95% CI = 0.95-1.39, P = .14; worry item: HR = 1.18, 95% CI = 0.99-1.42, P = .07).
DISCUSSION
In a large cohort of older adults in primary care, those initially free of diabetes mellitus who screened positive for anxiety had a 35% greater risk of developing diabetes mellitus over the 10-year follow-up period than those who did not, even after adjusting for demographic factors, diabetes mellitus risk factors, and depression screen status. Itemlevel analyses indicated that the feeling anxious item and the worry item both contributed to the overall predictive utility of the PRIME-MD anxiety screen. Results of supplemental analyses suggested that the observed association between anxiety and incident diabetes mellitus was not because impending diabetes mellitus onset led to anxiety or to poor perceived health or sleep disturbance. In contrast to anxiety, participants screening positive for depression were not at a significantly greater risk of diabetes mellitus. Altogether, these findings suggest that anxiety is a risk factor for incident diabetes mellitus in older adults independent of traditional risk factors and depression. Few studies have evaluated the association between anxiety and diabetes mellitus longitudinally, and even fewer have simultaneously examined more than one emotional factor. Prior studies that have prospectively examined depression and anxiety in the same study have used composite measures reflecting the presence of depression or anxiety or examined depression and anxiety in separate models only. [7] [8] [9] [10] Consequently, none can speak to the relative importance of one emotional factor over the other. Another cross-sectional study 21 examined the association between mood, anxiety, impulse control, and substance use disorders assessed using diagnostic interviews and diabetes mellitus diagnosis. When examined simultaneously, major depressive disorder was independently associated with a slightly greater prevalence of diabetes mellitus. Although those findings are seemingly inconsistent with those of the current study, they are also not directly comparable, given their cross-sectional nature and the inclusion of impulse control and substance use disorders in the same model. As the sparsity of this literature indicates, additional prospective studies that simultaneously examine depression and anxiety as predictors of diabetes mellitusrelated outcomes are needed. Nonetheless, the current findings are in line with studies reporting a positive association between anxiety and incident diabetes mellitus, 22, 23 and the magnitude of the association observed is consistent with results of a recent meta-analysis of cross-sectional studies. 3 What might account for the excess risk of diabetes mellitus that anxiety confers? Candidate biological mechanisms include sympathetic overactivity, 24, 25 hypothalamicpituitary-adrenal reactivity and other neuroendocrine changes, 26, 27 and systemic inflammation. 26, 28 For example, sympathetic overactivity has been strongly associated with anxiety disorders. 29 In turn, a marker of sympathetic overactivity-high resting heart rate-has been found to predict diabetes mellitus development. 30 Another example is systemic inflammation; it is hypothesized that the exaggerated neurobiological sensitivity to threat common in anxiety increases synthesis of various inflammatory markers. 28 In turn, these markers can inhibit insulin's intracellular signaling cascade, ultimately decreasing insulin sensitivity and accelerating diabetes mellitus development. 31, 32 Worthy of equal attention are the candidate behavioral mechanisms, including smoking, 33, 34 sleep disturbance, 35, 36 and nonadherence to diabetes mellitus prevention strategies. 37, 38 The association between anxiety and incident diabetes mellitus observed remained significant after adjustment for smoking status, suggesting that this association is independent of smoking. Similarly, the anxiety screen continued to predict incident diabetes mellitus after adjustment for sleep disturbance. Nevertheless, sleep disturbance remains a viable mechanism because the measure of sleep disturbance included only two items, which may have failed to capture important aspects of this construct. Last, anxiety is associated with nonadherence to diabetes mellitus prevention strategies, including physical activity and dietary behaviors, 37, 38 which could lead to a sedentary lifestyle, high energy intake, and ultimately obesity and diabetes mellitus onset. Future studies formally testing for mediation are needed to elucidate the mechanisms underlying the relationship between anxiety and incident diabetes mellitus.
It is surprising that an association between a positive depression screen and incident diabetes mellitus was not observed in light of findings from prior meta-analyses that establish such an association. 1, 2 Prior work has shown that depressive symptoms predicted 6-year increases in insulin resistance, a critical stage in the etiology of type 2 diabetes mellitus. 39 One possible explanation for the present results is the older age of the sample. Older adults are more likely to endorse the somatic-vegetative symptoms (e.g., fatigue, sleep disturbance, appetite changes) than the cognitiveaffective symptoms (e.g., depressed mood, anhedonia, concentration difficulties) of depression. 40 Because the two items constituting the PRIME-MD depression screen were cognitive-affective in nature, depressed participants with a somatic presentation may have been misclassified as negative for depression. Such misclassification could decrease the predictive utility of the depression screen. A related potential explanation arises from evidence suggesting that the somatic-vegetative symptoms of depression may be stronger predictors of diabetes mellitus-related outcomes than the cognitive-affective symptoms. 39, 41 The failure of the depression screen to assess the potentially more-predictive somatic-vegetative symptoms could have also lowered its predictive utility. A final possible explanation may be the moderate sensitivity of the depression measure, due to which participants with subthreshold symptoms may not have been identified as having depression. This may have attenuated the positive association between depression screen and incident diabetes mellitus, since both depressive disorders and subthreshold depressive symptoms predict incident diabetes mellitus. 1 In contrast, it is likely that the anxiety screen identified participants with subthreshold symptoms because of its higher sensitivity, resulting in this screen's greater predictive utility.
Limitations of the present study warrant discussion. First, it is likely that the use of brief screeners to detect depression and anxiety, rather than a structured clinical interview, led to some misclassification. Specifically, the anxiety screen had higher sensitivity and lower specificity, and the depression screen had lower sensitivity and higher specificity. For the anxiety screen particularly, it is likely that participants with subthreshold elevations of anxiety symptoms were classified as having anxiety. Additional studies that use structured clinical interviews to assess depressive and anxiety disorders are needed to augment these findings. Second, because only two of the three PRIME-MD anxiety items were used to screen participants for enrollment in the IMPACT trial, the third item ("Have you had an anxiety attack (suddenly feeling fear or panic)?") could not be included in the computation of the anxiety screen variable. Nevertheless, the effect of this omission may be limited because the third item would have further increased the sensitivity of what appears to be an already highly sensitive anxiety screen (44% screen positive rate; Table 1 ). Third, the diabetes mellitus indicators at baseline and follow-up did not distinguish between type 1 and type 2 diabetes mellitus, although by using a broad definition of diabetes mellitus at baseline, any individuals with type 1 or type 2 diabetes mellitus were probably excluded. Moreover, participants with type 2 diabetes mellitus were undoubtedly identified during the follow-up period because type 2 diabetes mellitus is overwhelmingly the most common type in adults, accounting for 90-95% of all diagnosed cases, 42 and new-onset type 1 diabetes mellitus is particularly rare in adults aged 60 years and older. 43 Finally, the findings may not generalize to younger adults or those of higher socioeconomic status, given that the sample was primarily older and economically disadvantaged.
In summary, despite anxiety symptoms and disorders being highly prevalent, the association between a positive anxiety screen and diabetes mellitus risk is less studied than that between depression and diabetes mellitus risk. This article reports unique evidence that anxiety may be a risk factor for diabetes mellitus in older adults, independent of depression screening status and traditional risk factors for the disease. Methodological strengths of the study include the large, diverse sample; a comprehensive analytical approach; and the high rate of incident diabetes mellitus identified using multiple data sources. Study findings indicate that anxiety symptoms require greater consideration and awareness in the context of diabetes mellitus risk assessment and primary prevention. For example, primary care providers may need to be cognizant of the potential risk of diabetes mellitus of older adults who screen positive for anxiety and may need to implement earlier, more-aggressive therapies for managing anxiety symptoms and traditional diabetes mellitus risk factors in this at-risk group. Furthermore, research is needed to evaluate whether incorporating anxiety treatments into existing diabetes mellitus prevention efforts can further prevent or delay diabetes mellitus.
